
    
      A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative
      Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus
      Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In
      Hospitalized Adults
    
  